Shock Clinical Trials

39 recruiting

Shock Trials at a Glance

228 actively recruiting trials for shock are listed on ClinicalTrialsFinder across 6 cities in 49 countries. The largest study group is Not Applicable with 69 trials, with the heaviest enrollment activity in Paris, Amiens, and Strasbourg. Lead sponsors running shock studies include Centre Hospitalier Universitaire, Amiens, Assistance Publique - Hôpitaux de Paris, and Hospices Civils de Lyon.

Treatments under study

About Shock Clinical Trials

Looking for clinical trials for Shock? There are currently 39 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Shock trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Shock clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 228 trials

Recruiting

Correlation Between Capillary Refill Time and Perfusion Index in Critically Ill Patients

Hemodynamics InstabilityShock State
Hospices Civils de Lyon250 enrolled2 locationsNCT07555041
Recruiting
Not Applicable

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock

Septic ShockSepsis - to Reduce Mortality in the Intensive Care Unit
University Hospital, Clermont-Ferrand750 enrolled27 locationsNCT07179276
Recruiting
Phase 4

CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

Shock, Cardiogenic
Ottawa Heart Institute Research Corporation346 enrolled3 locationsNCT05267886
Recruiting
Phase 2

Physiology of Unloading VA ECMO Trial

Cardiogenic Shock
University of Utah104 enrolled1 locationNCT06336655
Recruiting
Not Applicable

Early Norepinephrine Administration and Rapid Dose Adjustment

SepsisSeptic Shock
Siriraj Hospital600 enrolled6 locationsNCT07343206
Recruiting
Phase 1Phase 2

Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care

Shock, Cardiogenic
4TEEN4 Pharmaceuticals GmbH130 enrolled20 locationsNCT06832722
Recruiting

Role of Echocardiography and Ultrasound Indices in Resuscitation of Septic Shock Patients

Septic Shock
Ain Shams University40 enrolled1 locationNCT07550400
Recruiting
Not Applicable

Transcatheter AortiC Valve Implantation in aorTic stenosIs CardiogenIc Shock

Cardiogenic ShockAortic Stenosis
Rigshospitalet, Denmark30 enrolled1 locationNCT06638268
Recruiting
Phase 3

Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

PneumoniaSeptic ShockThe Critically Ill Patient is Requiring Intubation
Helwan University41 enrolled1 locationNCT07530146
Recruiting

The Prevalence of the Aortic to Radial Pressure Gradient in States of Shock, Outside the Context of Cardiac Surgery, a Prospective Study

Shock
Hospices Civils de Lyon180 enrolled6 locationsNCT06460519
Recruiting
Phase 3

Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock

Patients With Norepinephrine-refractory Vasoplegic Shock
Centre Hospitalier Universitaire Dijon390 enrolled1 locationNCT07063680
Recruiting

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

Critical IllnessShock
University of Nevada, Las Vegas30 enrolled1 locationNCT07020637
Recruiting

In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive Care Unit

Septic Shock
Niguarda Hospital20 enrolled1 locationNCT07230041
Recruiting

Altshock-2 REGISTRY

Cardiogenic Shock
Niguarda Hospital3,000 enrolled1 locationNCT04295252
Recruiting

Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study

SepsisSeptic ShockMultiorgan Failure
Seoul National University Bundang Hospital360 enrolled1 locationNCT07539883
Recruiting

Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota

DysbiosisHPVMycosis+5 more
Centre National de la Recherche Scientifique, France300 enrolled1 locationNCT07199998
Recruiting
Not Applicable

Early Preventive Left Ventricle Unloading After VA-ECMO for Refractory Cardiogenic Shock

Cardiogenic Shock Acute
Assistance Publique - Hôpitaux de Paris298 enrolled12 locationsNCT07027202
Recruiting
Phase 2

Study SOLACE SEPSIS

Septic ShockIntracranial Hypertension
University Hospital Pilsen40 enrolled1 locationNCT06634069
Recruiting
Phase 4

Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure

Heart FailureCardiogenic ShockKetone Body Metabolism+2 more
Institute for Clinical and Experimental Medicine12 enrolled1 locationNCT07527156
Recruiting
Not Applicable

Peripheral Perfusion Index-guided Fluid Resuscitation for Preventing Acute Skin Failure in Elderly Critically Ill Patients

SepsisSeptic ShockAcute Skin Failure
Ying Wang216 enrolled1 locationNCT07367113